IMELCIMENT
UNII T7U2Z3N6QH

Substance Identification & Data

This profile provides standardized clinical and technical data for Imelciment, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T7U2Z3N6QH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2845128-03-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
T7U2Z3N6QH
CAS Registry Number
2845128-03-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IMELCIMENT
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12918
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Imelciment. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IMELCIMENT

Common Names & Synonyms

IMELCIMENT [INN]
IMMUNOGLOBULIN (H-GAMMA4_L-KAPPA)_G4HCH2CH3, ANTI-(VIXTICIBART,MONOCLONAL ANTIBODY ALLOSTERIC AGONIST OF HOMO SAPIENS NPR1 (ATRIAL NATRIURETIC PEPTIDE RECEPTOR 1)), HOMO SAPIENS MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G4 (229-PROLINE,436-ARGININE,437-PHENYLALANINE,446-PROLINE), ANTI-(HUMAN NATRIURETIC PEPTIDE RECEPTOR A) (HUMAN MONOCLONAL REGN9035 .GAMMA.4-CHAIN), (227->8'),(230->11')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (10'-PROLINE,217'-HISTIDINE,218'-TYROSINE) (HUMAN .GAMMA.4-CHAIN C REGION C-TERMINAL FRAGMENT), DISULFIDE WITH HUMAN MONOCLONAL REGN9035 .KAPPA.-CHAIN

Technical Codes

REGN9035
REGN-9035